Bioethics News

Possible HIV Cure OK’d for Testing

(Union Times San Diego) – HIV patients will be given genetically modified stem cells in an attempt to effectively cure them of the infection, the first time this experimental therapy has been tried. Sangamo Biosciences, based in the Bay Area community of Richmond, received approval from federal regulators Tuesday to conduct the clinical trial. The therapy involves removing patients’ blood-forming stem cells, genetically editing them so they become resistant to HIV infection, and then placing them back into the patients.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.